We believe that addiction is a disease that can be treated, and we want to help you stay up to date with the latest research that you can use in your addiction medicine practice.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
45. Urine Drug Screens and Treatment Retention
42:06
42:06
Play later
Play later
Lists
Like
Liked
42:06
45. Urine Drug Screens and Treatment Retention In episode 45 we discuss urine drug screens and treatment retention. Michener PS, Knee A, Wilson D, Boama-Nyarko E, Friedmann PD. Association of random and observed urine drug screening with long-term retention in opioid treatment programs. Drug Alcohol Depend. 2024 Feb 1;255:111067. We also discuss st…
…
continue reading
44. Cannabis and CV Outcomes In episode 44 we discuss the association between cannabis use and cardiovascular outcomes. Jeffers AM, Glantz S, Byers AL, Keyhani S. Association of Cannabis Use With Cardiovascular Outcomes Among US Adults. J Am Heart Assoc. 2024 Mar 5;13(5):e030178. doi: 10.1161/JAHA.123.030178. Epub 2024 Feb 28. We also discuss the D…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
43. Alcohol Use Disorder Meds at Hospital Discharge
34:50
34:50
Play later
Play later
Lists
Like
Liked
34:50
In episode 43 we discuss prescribing medication for alcohol use disorder at hospital discharge. Bernstein EY, Et al. Outcomes After Initiation of Medications for Alcohol Use Disorder at Hospital Discharge. JAMA Netw Open. 2024 Mar 4;7(3):e243387. We also discuss grandparents raising grandchildren who’ve lost a parent to drug overdose, and how nativ…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
42. The Protective Effect of Buprenorphine
24:11
24:11
Play later
Play later
Lists
Like
Liked
24:11
In episode 42 we discuss how buprenorphine protects against fentanyl overdose. Zheng Dai, et al. Quantifying a potential protective effect of buprenorphine on fatality risk during acute fentanyl exposures. Journal of Substance Use and Addiction Treatment, Volume 158, 2024. 209252, ISSN 2949-8759. We also discuss semaglutide for alcohol use disorder…
…
continue reading
In episode 41 we discuss vaping for smoking cessation. Auer R, et al. Electronic Nicotine-Delivery Systems for Smoking Cessation. N Engl J Med. 2024 Feb 15;390(7):601-610. We also discuss the NarxCare addiction risk score and the recent increase in alcohol-related deaths. New York Times: Addiction Risk Scores Won’t Solve the Opioid Crisis CDC: Deat…
…
continue reading
Quick summaries of Episodes 31-40. 31. Injection Drug Use Frequency Before and After Take-Home Naloxone Training 32. Trazodone for sleep disturbance in opioid dependent patients maintained on buprenorphine: A double blind, placebo-controlled trial 33. Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medica…
…
continue reading
In this episode we discuss drug overdose after benzodiazepine prescriptions for anxiety and depression. Bushnell GA, et al. Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individuals. Addiction. 2023. We also talk about the war on recovery treatments and patients leaving the …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
39. Opioid Abstinence and Cognitive Function
31:06
31:06
Play later
Play later
Lists
Like
Liked
31:06
In this episode we discuss improvements in cognitive function with opioid abstinence. Kaur, G. Et Al. Effects of Abstinence From Opioid on Neuropsychological Performance in Men With Opioid Use Disorder: A Longitudinal Study. Journal of Addiction Medicine 17(5): p 557-562, 9/10 2023. We also talk about paramedics giving buprenorphine along with nalo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Articles that Changed Our Practice - Part 2
42:33
42:33
Play later
Play later
Lists
Like
Liked
42:33
In this episode we discuss 5 more articles that changed our addiction medicine practice. Chambers LC, et al. Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl. JAMA Netw Open. 2023; 6(9):e2334540. September 2023. (Episode 34) Caponnetto, P., et al. Varenicline and counseling for vaping ces…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Articles that Changed Our Practice - Part 1
38:50
38:50
Play later
Play later
Lists
Like
Liked
38:50
In this episode we discuss 5 articles that changed our addiction medicine practice. Mahdi Sheikh, et al. Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality: A Prospective Cohort Study. Ann Intern Med.2021;174:1232-1239. [Epub 27 July 2021]. (Episode 4) Santos GM, et al. Targeted Oral Naltrexone for Mild to Mo…
…
continue reading
In episode 38 we discuss an article comparing different treatments (and no treatment) for opioid use disorder. Robert Heimer, Anne C. Black, Hsiuju Lin, Lauretta E. Grau, David A. Fiellin, Benjamin A. Howell, Kathryn Hawk, Gail D’Onofrio, William C. Becker. Receipt of Opioid Use Disorder Treatments Prior to Fatal Overdoses and Comparison to No Trea…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
37. Injectable Vs. Sublingual Buprenorphine
46:46
46:46
Play later
Play later
Lists
Like
Liked
46:46
37. Injectable Vs. Sublingual Buprenorphine In episode 37 we discuss an article comparing injectable and sublingual buprenorphine. Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial. Marsden…
…
continue reading
In episode 36 we discuss an article about the mediators of problematic smartphone use. Christiane Arrivillaga, Caleb J. Hallauer, Christian Montag, Jon D. Elhai. Emotion dysregulation factors associated with problematic smartphone use severity: The mediating role of fear of missing out. Addictive Behaviors. Volume 143. 2023. https://doi.org/10.1016…
…
continue reading
In episode 35 we discuss whether eliminating prior auths leads to more buprenorphine prescribing. Christine PJ, Larochelle MR, Lin L, McBride J, Tipirneni R. Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder. JAMA Health Forum. 2023;4(10):e233549. We also discuss buprenorphine diversion, and th…
…
continue reading
In episode 24 we discuss prescribing 24 mg of buprenorphine daily. Chambers LC, Hallowell BD, Zullo AR, et al. Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl. JAMA Netw Open. 2023;6(9):e2334540. September 2023. We also discuss why Rite Aid filed for bankruptcy, and the FDA ban on mentho…
…
continue reading
In episode 33 we discuss overdose risk and polypharmacy: opioids, benzodiazepines, antipsychotics, and gabapentinoids. Domzaridou E, Carr MJ, Millar T, Webb RT, Ashcroft DM. Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mor…
…
continue reading
In episode 32 we discuss an article about trazodone for sleep in people with opioid use disorder on buprenorphine. Piyush Goyal, Dheeraj Kattula, Ravindra Rao, Roshan Bhad, Ashwani Kumar Mishra, Anju Dhawan. Trazodone for sleep disturbance in opioid dependent patients maintained on buprenorphine: A double blind, placebo-controlled trial. Drug and A…
…
continue reading
31: We discuss an article about how naloxone training impacts IV drug use. Colledge-Frisby S, Rathnayake K, Nielsen S, et al. Injection Drug Use Frequency Before and After Take-Home Naloxone Training. JAMA Netw Open. 2023;6(8):e2327319. We also discuss gambling self-exclusion and which professions use the most drugs. From the Pennsylvania Gaming Co…
…
continue reading
Quick summaries of Episodes 21-30. 21. SOAT for OUD: Short-Acting Opioid Agonists for Opioid Use Disorder: Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder 22. Contingency Management for Coronary Artery Disease: High-risk Coronary Plaque Regression in Cash-based Conti…
…
continue reading
In episode 30 we discuss an article about racial differences in the receipt of medications for opioid use disorder. Barnett ML, Meara E, Lewinson T, Hardy B, Chyn D, Onsando M, Huskamp HA, Mehrotra A, Morden NE. Racial Inequality in Receipt of Medications for Opioid Use Disorder. N Engl J Med. 2023 May 11;388(19):1779-1789. We also talk about opioi…
…
continue reading
In episode 29 we discuss an article about using varenicline and counseling for vaping cessation.. Caponnetto, P., Campagna, D., Ahluwalia, J.S. et al. Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial. BMC Med 21, 220 (2023). In other vaping-related news: From NYSCSH: Vape pens tha…
…
continue reading
In episode 28 we discuss an article about pain and addiction recovery. Ajay Manhapra, Elina A. Stefanovics, Taeho Greg Rhee, Robert A. Rosenheck, Persistence of significant pain interference following substance use disorder remission: Negative association with psychosocial and physical recovery, Drug and Alcohol Dependence, Volume 232, 2022, 109339…
…
continue reading
In episode 27 we discuss an article about the risk of developing opioid use disorder after the first opioid prescription. Kendler, K., Lönn, S., Ektor-Andersen, J., Sundquist, J., & Sundquist, K. (2022). Risk factors for the development of opioid use disorder after first opioid prescription: A Swedish national study. Psychological Medicine, 1-9. Fr…
…
continue reading
26. We discuss a new conceptual model of addiction recovery. Pytell, J.D., Chander, G., Thakrar, A.P. et al. Pytell, J.D., Chander, G., Thakrar, A.P. et al. Does a Survivorship Model of Opioid Use Disorder Improve Public Stigma or Policy Support? A General Population Randomized Experiment. J GEN INTERN MED 38, 1638–1646 (2023). We also talk about c…
…
continue reading
25. We discuss an article about high-dose buprenorphine induction. Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. From NPR: Drugmaker Mallinckrodt may renege on $1.7 billion opioid settlement ---------- This podcast off…
…
continue reading
24. We discuss updated data on the harms of smoking and the benefits of quitting. Thomson B, Emberson J, Lacey B, et al. Association Between Smoking, Smoking Cessation, and Mortality by Race, Ethnicity, and Sex Among US Adults. JAMA Netw Open. 2022;5(10):e2231480. We also discuss the drug supply shift from heroin to fentanyl, and how California wan…
…
continue reading
23. We discuss an article about the Eat-Sleep-Console approach to treat neonatal opioid withdrawal syndrome. Young LW, Ounpraseuth ST, et. al. ACT NOW Collaborative. Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal. N Engl J Med. 2023 Apr 30. doi: 10.1056/NEJMoa2214470. Epub ahead of print. PMID: 37125831. We also share how…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
22. Contingency Management for Coronary Artery Disease
28:34
28:34
Play later
Play later
Lists
Like
Liked
28:34
22. Contingency Management for Coronary Artery Disease 22: We discuss an article about contingency management and the regression of coronary plaques in HIV+ cocaine users. Lai, Hong PhD; Bluemke, David A. MD; Fishman, Elliot K. MD; Gerstenblith, Gary MD; Celentano, David D. ScD; Treisman, Glenn MD; Foster, Parker MS; Mandler, Raul MD; Khalsa, Jag M…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
21. SOAT for OUD: Short-Acting Opioid Agonists for Opioid Use Disorder
37:57
37:57
Play later
Play later
Lists
Like
Liked
37:57
21: We discuss an article about using short-acting opioids to treat opioid use disorder in the hospital. Thakrar, A.P., Uritsky, T.J., Christopher, C. et al. Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder. Addict Sci Clin Pract 18, 13 (2023). We also discuss compuls…
…
continue reading
What We Learned at ASAM2023 In this episode, we share what we learned at the 2023 American Society of Addiction Medicine Conference. Some links from the conference that you might like: Curbsiders Addiction Medicine Podcast ToxIC: Toxicology Investigators Consortium DrugsData from the Erowid Center CESAR: Center for Substance Use, Addiction, and Hea…
…
continue reading
11-20 Round-up Super busy? Here are quick summaries of the last 10 articles. Article list: 11. Impact of wine bottle and glass sizes on wine consumption at home: a within- and between- households randomized controlled trial 12. Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities 13. Prescription opioids and lon…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
20. Targeted Naltrexone for Binge Drinking
31:56
31:56
Play later
Play later
Lists
Like
Liked
31:56
20. Targeted Naltrexone for Binge Drinking In episode 20 we discuss an article about taking naltrexone as needed to reduce binge drinking among sexual and gender minority men. Santos GM, Ikeda J, Coffin P, Walker J, Matheson T, Ali A, McLaughlin M, Jain J, Arenander J, Vittinghoff E, Batki S. Targeted Oral Naltrexone for Mild to Moderate Alcohol Us…
…
continue reading
19. Patients’ Goals in Treatment In episode 19 we discuss an article about what is most important to patients in treatment for opioid use disorder. Reed, M.K., Smith, K.R., Ciocco, F. et al. Sorting through life: evaluating patient-important measures of success in a medication for opioid use disorder (MOUD) treatment program. Subst Abuse Treat Prev…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
18. Treating HCV in People Who Inject Drugs
40:29
40:29
Play later
Play later
Lists
Like
Liked
40:29
In episode 18 we discuss the Hepatitis C Real Option (HERO) Study about two different models of HCV treatment in people who inject drugs. Litwin AH, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Heo M, Arnsten J, Meissner P, Karasz A, Mckee MD, Ward JW, Johnson N, Pericot-Valverde I, Agyemang L, Stein ES, Thomas A, Borsuk C, …
…
continue reading
In episode 17 we discuss buprenorphine-naloxone vs. buprenorphine alone in pregnancy. Perry, Briana N. MD; Vais, Simone MD; Boateng, Jeffery O. MBchB, MPH; Jain, Mayuri MPH; Wachman, Elisha M. MD; Saia, Kelley A. MD. Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy. Journal of Addiction Medicine 16(6):p …
…
continue reading
16. Treating Opioid Use Disorder in Jail In episode 16 we discuss an article about in-jail medication for opioid use disorder and recidivism. Elizabeth A. Evans, Donna Wilson, Peter D. Friedmann. Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug and Alcohol Dependence, Volume 231, 2022, 109254, ISSN 0376-8…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
15. Buprenorphine vs. Methadone in Pregnancy
34:09
34:09
Play later
Play later
Lists
Like
Liked
34:09
In episode 15 we discuss buprenorphine vs. methadone in pregnancy. E.A. Suarez, K.F. Huybrechts, L. Straub, S. Hernández‑Díaz, H.E. Jones, H.S. Connery, J.M. Davis, K.J. Gray, B. Lester, M. Terplan, H. Mogun, and B.T. Bateman. Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy. N Engl J Med 2022; 387:2033-2044. Bruzelius E, Martins…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
14. Early Life Trauma and Opioid Use Disorder
29:25
29:25
Play later
Play later
Lists
Like
Liked
29:25
In episode 14 we discuss the connection between early life trauma, depression, anxiety, stress, and opioid use disorder. Effects of Early Life Trauma on Risks for Adult Opioid Use Disorder Are Mediated by Stress and Occur Independent of Depression and Anxiety. Dunn, Kelly E. PhD, MBA; Turner, Gavin M. BS; Oswald, Lynn M. PhD. Journal of Addiction M…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
13. Prescription Opioids and Cognitive Decline
25:30
25:30
Play later
Play later
Lists
Like
Liked
25:30
In episode 13 we discuss opioids and cognitive changes in older adults. Warner, NS, Hanson, AC, Schulte, PJ, Habermann, EB, Warner, DO, Mielke, MM. Prescription opioids and longitudinal changes in cognitive function in older adults: A population-based observational study. J Am Geriatr Soc. 2022; 1- 12. doi:10.1111/jgs.18030 https://agsjournals.onli…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
12. Methamphetamine and Opioid Overdose in Rural Communities
31:09
31:09
Play later
Play later
Lists
Like
Liked
31:09
In episode 12 we discuss overdoses related to methamphetamine and opioid use in rural areas. Korthuis PT, Cook RR, Foot CA, et al. Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities. JAMA Netw Open. 2022;5(8):e2226544. doi:10.1001/jamanetworkopen.2022.26544 August 2022 Rural Opioid Initiative ---------- We als…
…
continue reading
In episode 11 we discuss an article about the impact of wine bottle and glass size on consumption. Mantzari, E, Ventsel, M, Ferrar, J, Pilling, MA, Hollands, GJ, Marteau, TM. Impact of wine bottle and glass sizes on wine consumption at home: a within- and between- households randomized controlled trial. Addiction. 2022. ---------- We discuss non-ab…
…
continue reading
Short on time? In this episode we give you quick summaries of articles 1-10. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder Association of Dose Tapering With Overdose or Mental Healt…
…
continue reading
In episode 10 we discuss an article about buprenorphine tapering. Bozinoff N, Men S, Kurdyak P, Selby P, Gomes T. Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper. JAMA Netw Open. 2022;5(9):e2234168. ---------- Take a look at Riggs, KR, DeRussy, AJ, Leisch, L, et al. Sensitivity of health records for self-re…
…
continue reading
In episode 9 we discuss psilocybin for treating alcohol use disorder. Bogenschutz MP, Ross S, Bhatt S, et al. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2022;79(10):953–962. ---------- We talk abo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
8. Opioid Tapering and Risk of Suicide and Overdose
35:42
35:42
Play later
Play later
Lists
Like
Liked
35:42
In episode 8 we discuss the article about opioid tapering and discontinuation, and the risks of suicide and overdose. Larochelle MR, Lodi S, Yan S, Clothier BA, Goldsmith ES, Bohnert ASB. Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
7. Treating Opioid and Polysubstance Use Disorders
34:18
34:18
Play later
Play later
Lists
Like
Liked
34:18
In Episode 7 we discuss treating opioid use disorder with co-occurring polysubstance use. Xu KY, Mintz CM, Presnall N, Bierut LJ, Grucza RA. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use. JAMA Netw Open. 2022;5(5):e2211363. 2022 Aug 3. We also discuss the Society of H…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
6. A BZD-Sparing Alcohol Withdrawal Protocol
27:58
27:58
Play later
Play later
Lists
Like
Liked
27:58
In episode 6 we discuss a benzodiazepine-sparing alcohol withdrawal protocol. Smith JT, Sage M, Szeto H, et al. Outcomes After Implementation of a Benzodiazepine-Sparing Alcohol Withdrawal Order Set in an Integrated Health Care System. JAMA Netw Open. 2022;5(2):e220158. 2022 Feb 2. We also discuss long-term outcomes from a primary-care based MAT cl…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
5. Clinical Effects of Medical Marijuana Cards
31:20
31:20
Play later
Play later
Lists
Like
Liked
31:20
Episode 5 discusses the clinical effects of getting a medical marijuana card. Gilman JM, Schuster RM, Potter KW, et al. Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(3):e222106. If you want an introduction on how to manage medical marijuan…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
4. Smoking Cessation After Lung Cancer Diagnosis
25:17
25:17
Play later
Play later
Lists
Like
Liked
25:17
Episode 4 discusses the benefits of smoking cessation after a diagnosis of lung cancer. Mahdi Sheikh, Anush Mukeriya, Oxana Shangina, et al. Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality: A Prospective Cohort Study. Ann Intern Med.2021;174:1232-1239. [Epub 27 July 2021]. We also talk about whether or not…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
2: Prescribing Stimulants for Patients on Buprenorphine
26:56
26:56
Play later
Play later
Lists
Like
Liked
26:56
In episode 2 we discuss the safety of prescribing stimulants for patients receiving buprenorphine. Article Citation: Mintz CM, Xu KY, Presnall NJ, et al. Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder. JAMA Netw Open. 2022;5(5):e2211634. doi:10.1001/jamanet…
…
continue reading